Literature DB >> 30248037

Evaluation of balance after surgery for cerebellopontine angle tumor.

Nurayet Canbaz1, Esra Atılgan1, Ela Tarakcı2, Meliha Gündağ Papaker3.   

Abstract

BACKGROUND: The origin of about 10% of tumors located in the intracranial region is the cerebellopontine angle. Therefore Cerebellopontine Angle (CPA) tumors affect patients' balance.
OBJECTIVE: The aim of this study was to compare the balance in individuals who underwent surgery for CPA tumors with healthy individuals.
METHODS: Thirty patients who were being followed-up by the Department of Neurosurgery and had been operated on CPA tumor and 31 healthy individuals were included in the study as group 1 and group 2, respectively. The participants were evaluated using Romberg Test, Sharpened Romberg Test, One-leg Stance (OLS), Tandem Walking, Walk Across, Berg Balance Scale (BBS), Dizziness Handicap Inventory (DHI) and Short Form 36 (SF-36).
RESULTS: In comparison of the groups, OLS tests (p< 0.001), BBS (p< 0.05) and DHI (p< 0.05) were significantly different in favor of healthy group. SF-36 results revealed a significant difference between the groups, except for Bodily Pain and Vitality (p< 0.05).
CONCLUSIONS: The results of this study demonstrated a decrease in balance parameters and quality of life in individuals who underwent CPA tumor surgery in comparison to healthy individuals. Evaluation of balance in the preoperative and postoperative period should not be ignored in these patients and they are suggested to start rehabilitation in the early postoperative period.

Entities:  

Keywords:  Cerebellopontine angle tumors; balance; dizziness

Mesh:

Year:  2019        PMID: 30248037     DOI: 10.3233/BMR-181198

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  1 in total

1.  Postoperative headache after surgical treatment of cerebellopontine angle tumors: a systematic review.

Authors:  Louis Pogoda; Jelle S Nijdam; Diederik P J Smeeing; Eduard H J Voormolen; Fuat Ziylan; Hans G X M Thomeer
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-02-01       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.